We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/11/2013 09:39 | Yes, thank you for IDEA GHF. Profit is always greatly appreciated. Jingle bells.... | simon gordon | |
06/11/2013 09:26 | Thanks to GHF on this one! | chizgreen68 | |
06/11/2013 09:22 | Morning Cheshire Man, another winner for the team :)) | battlebus2 | |
06/11/2013 08:58 | Good morning all,,,,,,,,,excellen | cheshire man | |
06/11/2013 08:43 | Break through 25p on more buying. This Plum tree is bearing fruit. | lanzarote666 | |
06/11/2013 08:30 | Yep, slowly getting recognition. I had set myself an initial 30p target here but seems this will be just for starters. Nice one GHF thanks :)) | battlebus2 | |
06/11/2013 08:27 | Onwards and upwards. Positive and upbeat. But so quiet on here and under so many radars. Suggests much more to come. I think the brokers may have to revise that 27p target forecast. 8-) | lanzarote666 | |
06/11/2013 07:46 | Agree entirely battlebus...as I tweeted. @Glasshalfull1: IDEA @Ideagen_Plc Strong t/s & establishment of dividend Net cash 25% of Cap. Fantastic growth story emerging #TMFPP Regards, GHF | glasshalfull | |
06/11/2013 07:15 | Excellent trading update with maiden dividend to come. | battlebus2 | |
03/10/2013 08:50 | Presentation must have been positive given the buys this morning. | battlebus2 | |
20/9/2013 17:05 | Ideagen will be presenting at ShareSoc's second technology company seminar on 2nd October. The event takes place in the City of London, with registration beginning at 5:30pm and presentations starting at 5:55pm. If you would like to attend, free-of-charge, please pre-register here: hxxp://www.sharesoc. ShareSoc is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. For more about us, see this: hxxp://www.sharesoc. Other companies presenting at the event are: Armour Group (AIM:AMR) and Regenersis (AIM:RGS). Cheers, Mark | marben100 | |
12/9/2013 11:30 | Thanks, Masurenguy - keep us informed. | welsheagle | |
10/9/2013 21:19 | Thanks for the links and info. Looks like there's someone selling into strength at the moment near the resistance on the chart. Perhaps once that's cleared it will make a break for freedom. | yump | |
10/9/2013 17:17 | Agree. Cheers hastings...have tweeted the link ;-) Regards GHF | glasshalfull | |
10/9/2013 16:26 | Thanks Mas an interesting read. | battlebus2 | |
10/9/2013 16:20 | Transcript Generating ideas is the way ahead When it comes to smaller companies delivering impressive growth, it's seldom driven purely organically. Moreover, it is often acquisition-led, with the organic element evolving after the integration process of bolt-on purchases have been bedded down. While there are a number of stocks out there with prospects, few tick the right boxes for me, although I confess to feeling that Matlock-based Ideagen does warrant a closer look. At the current 21p per share, and with a market cap of £25m, this provider of software management solutions addressing the vast area of industry compliance has been making some decent headway over the last few years, and appears well placed to continue on a growth path. A quick glance at Ideagen's revenues reveals sales gathering momentum having moved up from just a few hundred thousand in 2009 to the most recent £6.5m delivered for the year ended April of this year. And it is worth noting that those last numbers represented a significant 63% increase on the previous year. Although there have been acquisitions here which have contributed to the sales surge, there is also some decent organic growth feeding through along with the welcome addition of solid recurring revenues. Perhaps more attractive from a potential investment perspective is the ability of the company to generate cash and thus far, the boards reliability to deliver on anticipated numbers. With the company focused on providing its services to highly regulated industries such as health care, construction, aerospace and defence, along with utilities, there should be plenty of opportunities for the company ahead. In fact, within healthcare, whereby it already serves more than 350 hospitals across both the UK and the US, it looks well placed to further capitalise on progress already made. Its solutions and offerings which take in training, installation and maintenance are perhaps ideally suited for markets such as health-providing cost savings, efficiency and the raising of standards. Ideagen can also boast a specialist division purely dedicated to the NHS market with solutions delivered for the likes of patient medical record management, as one example. And that area could well be boosted by the company's most recent acquisition in the form of MSS, which follows on from the purchase of Proquis in 2011 and Plumtree which was acquired in 2012. This latest addition is focused on information management solutions delivering its Patient First product to the Accident and Emergency departments of at least 10 Acute trusts within England. Given the ongoing concerns in relation to A&E departments coming under increased pressure, any system that enhances the service or helps manage vast numbers flowing through the system should be likely to benefit further ahead. Thus far, the enlarged Ideagen is performing well and successfully raised £6m in an over-subscribed placing last year which contributed to the purchase of Plumtree, a complementary business also UK-based which provides strong synergies and further opportunities. One minor hiccup came in the form of the early termination of a contract in the US when the Dept of Veteran Affairs found its budget coming under pressure. Although an inconvenience, it didn't really impact on the share price or it would seem the longer term business potential. Since then, the company has delivered its preliminary results which were released back in July and things appear well on track. Solid cash generation along with a decent line of recurring revenue saw pre-tax profits after amortisation and intangibles related to the acquisitions come in at £1.8m. Cash on the balance sheet is also solid standing at £6.3m, which gives the company more scope to add another complementary business should it choose to do so. Additionally, a further contract was also announced with the Dartford and Gravesham NHS Trust signing up for a document management solution. Broker FinnCap is forecasting adjusted pre-tax profits of £2.6m for next year which would give EPS of 1.6p putting the shares on a forward PER of just over 12. While that may not appear overly cheap, it is nevertheless at a discount to peers and needs to be looked at in the context of how quickly the business may grow over the next few years and beyond. Of course, some may want to see more evidence of the board's ability to maximise the benefits from the acquisitions and that is reasonable. However, if it does continue in the recent vein, then the shares in turn could appreciate quite quickly and achieve the current broker target price of 27p. Major holders include Investec, Octopus, ISIS and Amati Global. | masurenguy | |
10/9/2013 13:27 | May be of interest. hxxp://www.cambridge | hastings | |
10/9/2013 08:17 | Techno20 I missed those brands on first read ! Am I getting mixed up but is the Veteran's SaaS contract likely to be some sort of replacement for the previous contract which got cut back, partly ? Rushing around atm so can't read stuff properly. | yump | |
10/9/2013 08:13 | Bright start this morning. | battlebus2 | |
09/9/2013 18:53 | I would not be surprised to see a positive update from Shares Magazine later this week. They were bullish at 16p in August 2012 and recommended as a buy at 20.8p in May 2013, citing that the rating was too low given that 90% of costs are covered by recurring revenues. | lanzarote666 | |
09/9/2013 18:06 | Nice to come back to a positive update tonight ;-) As Techno notes in the post above, it's worth reading the entire RNS as a number of positive aspects become apparent...their biggest NHS contract; continued success in US & notable wins in other markets. Well done to the IDEA team! Regards, GHF | glasshalfull | |
09/9/2013 17:45 | Been monitoring these for 6 months or so, and couldn't resist taking a bite when they drifted back late morning. Thought the wording of the statement was extremely positive. There are some serious brand names in the last but one para, which seemed almost to be added as an afterthought! "Outside of the healthcare sector, demand for the Company's products and services has remained strong with notable contracts received from the Prudential, Tata Motors, Fuji Diosyth, Mouchel and Marsh Insurance". Feels like momentum building steadily. GLA Techno | techno20 | |
09/9/2013 15:43 | Bought a few more as long term this is a sure winner imv dyor etc. | battlebus2 | |
09/9/2013 11:20 | Surprised to see a little retrace after this mornings news but the sooner our seller has gone the better. | battlebus2 | |
09/9/2013 08:32 | I managed a very timely buy for once ! | yump |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions